Policy and programme considerations for ARV-based prevention for women: Insights from key opinion leaders in Zimbabwe about tenofovir gel
暂无分享,去创建一个
B. Friedland | M. Brady | S. Mullick | S. Dube | McGrory Ce
[1] C. Wiysonge,et al. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis , 2012, BMC Infectious Diseases.
[2] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[3] J. Hargrove,et al. Declining HIV prevalence and incidence in perinatal women in Harare, Zimbabwe. , 2011, Epidemics.
[4] Lynn Morris,et al. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women , 2010, Science.
[5] J. H. van de Wijgert,et al. Phase 1 Trial of the Topical Microbicide BufferGel: Safety Results From Four International Sites , 2001, Journal of acquired immune deficiency syndromes.